Skip to content

Immunovant, Inc. IMVT Business Segments — Personnel-related general and administrative

Similar metrics at other companies

Enphase Energy logo
ENPHReportable Segment — Other general and administrative
$20.35M-4.0%
Vaxcyte, Inc. logo
PCVXReportable Segment — G&A
$33.07M+1.3%
Veradermics
 logo
MANEReportable Segment — General and administrative, excluding personnel expenses
$4.61M+339%
Mirum Pharmaceuticals, Inc. logo
MIRMReportable Segment — General and administrative expenses (excluding stock-based compensation)
$19.18M+64.2%
Rhythm Pharmaceuticals, Inc. logo
RYTMSingle reportable segment — Corporate, general & administrative
$7.89M-1.2%
Tradeweb Markets Inc. logo
TWReportable Segment — G&A
$11.94M-39.5%

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$7.26B+74.2%
Enterprise value$6.35B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0.0×
Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.

The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s business segments — personnel-related general and administrative.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immunovant, Inc.'s business segments — personnel-related general and administrative?
Immunovant, Inc. (IMVT) reported business segments — personnel-related general and administrative of $10.13M in Q1 2026.
How has Immunovant, Inc.'s business segments — personnel-related general and administrative changed year-over-year?
Immunovant, Inc.'s business segments — personnel-related general and administrative increased by 8.9% year-over-year, from $9.3M to $10.13M.
What is the long-term trend for Immunovant, Inc.'s business segments — personnel-related general and administrative?
Over 3 years (2023 to 2026), Immunovant, Inc.'s business segments — personnel-related general and administrative has grown at a 20.4% compound annual growth rate (CAGR), from $27.91M to $48.73M.
What does business segments — personnel-related general and administrative mean?
Includes all salary, benefits, and related compensation costs for administrative and support staff within the reportable segment. This metric reflects the fixed operational overhead required to manage the business, excluding direct research activities. It serves as a key measure of the company's administrative efficiency and organizational scaling.